Owlet, Inc.

NYSE:OWLT

Medical - Devices

Healthcare
$3.67 +9.76%

+$0.46 today

Market cap
$107.24M
Beta
1.86
P/E (TTM)
-0.4
EPS (TTM)
-$12.67
52W Low $4.19High $16.94

Volume 0.64M

Average 0.24M

OWLT Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Owlet, Inc.NYSE: OWLT

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares dips below year-ago levels

Q1 FY2026 weighted avg shares of 3.63M shares fell 76.4% year over year, behind the +1085.6% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 99.4% from the prior quarter. Over 3 fiscal years it compounded at +313.6% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -76.4% toward the trailing-twelve-month pace of +1085.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
3.63M-99.4% QoQ
Last fiscal yearDec 2025
562.5M+3623.1% YoY
LTMMar 2026
149.39M+1085.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-76.4%——
1 year+3623.1%——
3-year CAGR+313.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
562.5M USD
Year-over-year change
+3623.1%
4-year CAGR
+190.7%

Weighted Avg Shares vs competitors

How OWLT compares with its peers on the latest reported figures

  • OWLT's LTM Mar 2026 weighted avg shares of 149.39M shares is the highest of the 10 companies compared; the peer median is 23.58M shares.
  • Its year-over-year change of +1085.6% is the highest of 10, against a peer median of +3.8%.
  • Over three fiscal years its annual growth of +313.6% compares with a peer median of +5.6%.
OWLT Competitors Peer median
Weighted Avg Shares for OWLT and competitors
Company Period LTM YoY 3-year CAGR
OWLTOwlet, Inc.LTM Mar 2026149.39M +1085.6%+313.6%
MXCTMaxCyte, Inc.LTM Mar 2026106.51M +1.3%+1.5%
LUCDLucid Diagnostics Inc.LTM Mar 2026102.76M +82.6%+41.3%
CRDFCardiff Oncology, Inc.LTM Mar 202667.15M +30.5%+15.3%
RPIDRapid Micro Biosystems, Inc.LTM Mar 202644.81M +2.4%+1.7%
AVRAnteris Technologies Global Corp.LTM Mar 202623.58M -20.8%-13.1%
ELTXElicio Therapeutics, Inc.LTM Mar 202616.57M +32.5%+70.3%
ANIKAnika Therapeutics, Inc.LTM Mar 202614.15M -3.2%-0.5%
CRBPCorbus Pharmaceuticals Holdings, Inc.LTM Mar 202612.8M +30.5%+47.3%
LNSRLENSAR, Inc.LTM Mar 202612.05M +3.8%+5.6%
Peer median (excluding OWLT) 23.58M+3.8%+5.6%

Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue75.84M69.2M54.01M78.06M105.71M
Cost of Revenue40.78M45.89M31.42M38.75M52.18M
Gross Profit35.06M23.31M22.59M39.31M53.53M
Gross Margin46.2%33.7%41.8%50.4%50.6%
Research & Development21.43M27.9M10.35M9.8M14.08M
Selling, General & Admin69.42M80.04M40.87M49.73M47.72M
Operating Expenses90.85M107.93M51.22M59.53M61.79M
Depreciation & Amortization1.13M2.67M2.21M1.38M590K
EBITDA(42.71M)(75.53M)(27.49M)(9.47M)(35.64M)
EBITDA Margin-56.3%-109.1%-50.9%-12.1%-33.7%
Operating Income(55.79M)(84.62M)(28.63M)(20.22M)(8.26M)
Operating Margin-73.6%-122.3%-53.0%-25.9%-7.8%
Interest Income00000
Interest Expense27.83M1.1M3.19M1.63M3.42M
Other Income / Expenses(15.88M)5.31M(4.26M)7.74M(31.39M)
Income Before Tax(71.67M)(79.31M)(32.89M)(12.48M)(39.65M)
Pre-Tax Margin-94.5%-114.6%-60.9%-16.0%-37.5%
Income Tax Expense31K29K10K54K28K
Net Income(71.7M)(79.34M)(32.9M)(12.54M)(39.68M)
Net Margin-94.5%-114.6%-60.9%-16.1%-37.5%
EPS (Basic)(12.47)(9.97)(4.53)(0.83)(2.24)
EPS (Diluted)(12.47)(9.97)(4.53)(0.83)(2.24)
Weighted Avg Shares7.87M7.95M8.28M15.11M562.5M
Weighted Avg Shares (Diluted)7.87M7.95M8.28M15.11M562.5M

Owlet, Inc.

NYSE:OWLT

Intrinsic Alpha fair value

Locked

Current Price

$3.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.